PT1833810T - Modificações cristalinas de n-alfa-(2,4,6-triisopropil-fenilsulfonil)-3-hidroxiamidino-(l)-fenilalanina-4--etoxicarbonilpiperazida e/ou seus sais - Google Patents
Modificações cristalinas de n-alfa-(2,4,6-triisopropil-fenilsulfonil)-3-hidroxiamidino-(l)-fenilalanina-4--etoxicarbonilpiperazida e/ou seus saisInfo
- Publication number
- PT1833810T PT1833810T PT58084013T PT05808401T PT1833810T PT 1833810 T PT1833810 T PT 1833810T PT 58084013 T PT58084013 T PT 58084013T PT 05808401 T PT05808401 T PT 05808401T PT 1833810 T PT1833810 T PT 1833810T
- Authority
- PT
- Portugal
- Prior art keywords
- ethoxycarbonylpiperazide
- triisopropylphenylsulfonyl
- hydroxyamidino
- phenylalanine
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004057195A DE102004057195A1 (de) | 2004-11-26 | 2004-11-26 | Kristalline Modifikationen von N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1833810T true PT1833810T (pt) | 2017-12-11 |
Family
ID=35811673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT58084013T PT1833810T (pt) | 2004-11-26 | 2005-11-24 | Modificações cristalinas de n-alfa-(2,4,6-triisopropil-fenilsulfonil)-3-hidroxiamidino-(l)-fenilalanina-4--etoxicarbonilpiperazida e/ou seus sais |
Country Status (17)
Country | Link |
---|---|
US (2) | US7713980B2 (pt) |
EP (1) | EP1833810B1 (pt) |
JP (1) | JP5054538B2 (pt) |
KR (2) | KR101455788B1 (pt) |
CN (1) | CN1989118B (pt) |
AU (1) | AU2005308977B2 (pt) |
BR (1) | BRPI0514823A (pt) |
CA (1) | CA2581959C (pt) |
DE (1) | DE102004057195A1 (pt) |
DK (1) | DK1833810T3 (pt) |
ES (1) | ES2645567T3 (pt) |
HU (1) | HUE037259T2 (pt) |
MX (1) | MX2007001420A (pt) |
PL (1) | PL1833810T3 (pt) |
PT (1) | PT1833810T (pt) |
RU (1) | RU2388754C2 (pt) |
WO (1) | WO2006056448A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040815B (zh) * | 2011-10-13 | 2014-12-10 | 中国科学院上海药物研究所 | 一类2,4,6-三异丙基苯类化合物在制备治疗糖尿病的药物中的用途 |
CN105566327A (zh) * | 2014-10-09 | 2016-05-11 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法 |
CA2997671A1 (en) * | 2015-10-06 | 2017-04-13 | Redhill Biopharma Ltd. | Combination therapies for treating cancer |
JOP20210072A1 (ar) * | 2018-10-31 | 2023-01-30 | Servier Lab | ملح جديد لمثبط bcl-2، صورة بلورية ذات صلة، طريقة تحضيره وتركيبات صيدلية تحتوي عليه |
EP4117630A1 (en) | 2020-03-10 | 2023-01-18 | RedHill Biopharma Ltd. | Treatment of coronavirus infection |
US11471448B2 (en) | 2020-12-15 | 2022-10-18 | Redhill Biopharma Ltd. | Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE50211672D1 (de) | 2001-03-21 | 2008-03-27 | Wilex Ag | Urokinase-inhibitoren |
SI21137A (sl) | 2002-01-24 | 2003-08-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Derivati azafenilalanina |
CH695999A5 (de) | 2002-02-28 | 2006-11-15 | Wilex Ag | Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten. |
AU2003253326A1 (en) | 2002-07-25 | 2004-02-16 | Wilex Ag | Method for the production of phenylalanine derivatives |
DE10323898A1 (de) | 2003-05-26 | 2004-12-23 | Wilex Ag | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
DE102004045720A1 (de) * | 2004-09-21 | 2006-03-23 | Wilex Ag | Stabile Dosierungsform von Phenylalanin-Derivaten |
-
2004
- 2004-11-26 DE DE102004057195A patent/DE102004057195A1/de not_active Ceased
-
2005
- 2005-11-24 HU HUE05808401A patent/HUE037259T2/hu unknown
- 2005-11-24 AU AU2005308977A patent/AU2005308977B2/en active Active
- 2005-11-24 KR KR1020137011330A patent/KR101455788B1/ko active IP Right Grant
- 2005-11-24 ES ES05808401.3T patent/ES2645567T3/es active Active
- 2005-11-24 KR KR1020077004417A patent/KR101311329B1/ko active IP Right Grant
- 2005-11-24 US US11/664,266 patent/US7713980B2/en active Active
- 2005-11-24 EP EP05808401.3A patent/EP1833810B1/de active Active
- 2005-11-24 DK DK05808401.3T patent/DK1833810T3/da active
- 2005-11-24 CA CA2581959A patent/CA2581959C/en active Active
- 2005-11-24 PT PT58084013T patent/PT1833810T/pt unknown
- 2005-11-24 BR BRPI0514823-5A patent/BRPI0514823A/pt not_active Application Discontinuation
- 2005-11-24 MX MX2007001420A patent/MX2007001420A/es active IP Right Grant
- 2005-11-24 RU RU2007123712/04A patent/RU2388754C2/ru active
- 2005-11-24 WO PCT/EP2005/012589 patent/WO2006056448A1/de active Application Filing
- 2005-11-24 JP JP2007541847A patent/JP5054538B2/ja active Active
- 2005-11-24 PL PL05808401T patent/PL1833810T3/pl unknown
- 2005-11-24 CN CN2005800249441A patent/CN1989118B/zh active Active
-
2010
- 2010-03-29 US US12/749,140 patent/US8492385B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2007001420A (es) | 2007-04-19 |
CA2581959C (en) | 2013-08-06 |
CN1989118B (zh) | 2012-11-14 |
AU2005308977A1 (en) | 2006-06-01 |
KR101455788B1 (ko) | 2014-11-04 |
KR20070083507A (ko) | 2007-08-24 |
CA2581959A1 (en) | 2006-06-01 |
JP5054538B2 (ja) | 2012-10-24 |
DE102004057195A1 (de) | 2006-06-01 |
KR20130066700A (ko) | 2013-06-20 |
CN1989118A (zh) | 2007-06-27 |
ES2645567T3 (es) | 2017-12-05 |
EP1833810B1 (de) | 2017-08-30 |
DK1833810T3 (da) | 2017-12-04 |
US7713980B2 (en) | 2010-05-11 |
BRPI0514823A (pt) | 2008-06-24 |
US20100266679A1 (en) | 2010-10-21 |
HUE037259T2 (hu) | 2018-08-28 |
US20080058346A1 (en) | 2008-03-06 |
WO2006056448A1 (de) | 2006-06-01 |
US8492385B2 (en) | 2013-07-23 |
PL1833810T3 (pl) | 2018-01-31 |
JP2008521764A (ja) | 2008-06-26 |
KR101311329B1 (ko) | 2013-09-25 |
RU2388754C2 (ru) | 2010-05-10 |
EP1833810A1 (de) | 2007-09-19 |
RU2007123712A (ru) | 2009-01-10 |
AU2005308977B2 (en) | 2011-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL192241A (en) | A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts | |
TWI372752B (en) | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | |
IL184059A0 (en) | Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexylphenyl]piperazine | |
HK1172618A1 (zh) | 取代的嗎啉和硫代嗎啉衍生物 | |
TWI349649B (en) | Structurally modified titanium dioxides | |
IL195346A0 (en) | Novel heterocyclic compound or salt thereof and intermediate thereof | |
EP1900732A4 (en) | NOVEL HETEROCYCLIC NITROGENIC COMPOUND AND SALT THEREOF | |
SI3056492T1 (sl) | Sol meglumina in njene kristalinične oblike zdravila (delafloksacin) | |
HK1148533A1 (en) | Prodrugs of piperazine and substituted piperidine antiviral agents | |
IL175123A0 (en) | Crystalline ammonium salts of rosuvastatin | |
PL378587A1 (pl) | Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli | |
IL181677A0 (en) | Substituted heterocyclic compounds and uses thereof | |
IL189781A0 (en) | Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same | |
EP2085383A4 (en) | Piperidin derivatives or salts thereof | |
IL178461A0 (en) | Substituted 4-alkyl -and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists | |
EP1773339A4 (en) | CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE | |
PL1833810T3 (pl) | Krystaliczne modyfikacje N-alfa-(2,4,6-triizopropylofenylosulfonylo)-3-hydroksyamidyno-(L)- fenyloalanino-4-etoksykarbonylopiperazydu i/lub jego soli | |
EP1898755A4 (en) | PILLAR PINE SELECTION AND POVERTY EVALUATION | |
EP1767531A4 (en) | MEDICINAL COMPOSITIONS CONTAINING 6-HYDROXYBENZBROMARONE OR SALTS THEREOF | |
EP1852432A4 (en) | NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE | |
EP1623972A4 (en) | SOLID N-ACYLALANINE OR SALTS THEREOF | |
ZA200804816B (en) | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | |
IL186221A0 (en) | Crystalline rosuvastatin intermediate | |
HK1127862A1 (en) | Piperazine compound and pyridine compound | |
AU2003232062A8 (en) | Heterocyclic amine diol compounds and their biocidal derivatives |